Found 3 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Beta-1 adrenergic receptor
(Homo sapiens (Human)) | BDBM50313943
((R)-(1H-benzo[d]imidazol-2-yl)methyl 4-(2-(2-hydro...)Show SMILES O[C@@H](CNCCc1ccc(NC(=O)OCc2nc3ccccc3[nH]2)cc1)c1cccnc1 |r| Show InChI InChI=1S/C24H25N5O3/c30-22(18-4-3-12-25-14-18)15-26-13-11-17-7-9-19(10-8-17)27-24(31)32-16-23-28-20-5-1-2-6-21(20)29-23/h1-10,12,14,22,26,30H,11,13,15-16H2,(H,27,31)(H,28,29)/t22-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 840 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]cyanopindolol from human beta 1 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter |
Bioorg Med Chem Lett 20: 1895-9 (2010)
Article DOI: 10.1016/j.bmcl.2010.01.130 BindingDB Entry DOI: 10.7270/Q2639QPK |
More data for this Ligand-Target Pair | |
Beta-2 adrenergic receptor
(Homo sapiens (Human)) | BDBM50313943
((R)-(1H-benzo[d]imidazol-2-yl)methyl 4-(2-(2-hydro...)Show SMILES O[C@@H](CNCCc1ccc(NC(=O)OCc2nc3ccccc3[nH]2)cc1)c1cccnc1 |r| Show InChI InChI=1S/C24H25N5O3/c30-22(18-4-3-12-25-14-18)15-26-13-11-17-7-9-19(10-8-17)27-24(31)32-16-23-28-20-5-1-2-6-21(20)29-23/h1-10,12,14,22,26,30H,11,13,15-16H2,(H,27,31)(H,28,29)/t22-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]cyanopindolol from human beta 2 adrenergic receptor expressed in CHO cells at 10 uM after 3 to 4 hrs by scintillation counter |
Bioorg Med Chem Lett 20: 1895-9 (2010)
Article DOI: 10.1016/j.bmcl.2010.01.130 BindingDB Entry DOI: 10.7270/Q2639QPK |
More data for this Ligand-Target Pair | |
Beta-3 adrenergic receptor
(Homo sapiens (Human)) | BDBM50313943
((R)-(1H-benzo[d]imidazol-2-yl)methyl 4-(2-(2-hydro...)Show SMILES O[C@@H](CNCCc1ccc(NC(=O)OCc2nc3ccccc3[nH]2)cc1)c1cccnc1 |r| Show InChI InChI=1S/C24H25N5O3/c30-22(18-4-3-12-25-14-18)15-26-13-11-17-7-9-19(10-8-17)27-24(31)32-16-23-28-20-5-1-2-6-21(20)29-23/h1-10,12,14,22,26,30H,11,13,15-16H2,(H,27,31)(H,28,29)/t22-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | >10 | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Agonistic activity at human beta3 adrenergic receptor expressed in CHO cells assessed as amount of cAMP released after 1 hr by fluorescence resonance... |
Bioorg Med Chem Lett 20: 1895-9 (2010)
Article DOI: 10.1016/j.bmcl.2010.01.130 BindingDB Entry DOI: 10.7270/Q2639QPK |
More data for this Ligand-Target Pair | |